Position history for CITADEL ADVISORS LLC's holdings in ACRIVON THERAPEUTICS INC
CITADEL ADVISORS LLC holds 1.6M shares of ACRV (ACRIVON THERAPEUTICS INC), worth $4M as of 2025-Q4. The position was increased (++6.5% shares). ACRV represents 0.0% of CITADEL ADVISORS LLC's portfolio.
Current Value
$4M
Current Shares
1.6M
Total Value Change
-$8.3M
Total Shares Change
-477,762
Other major holders of ACRV: RA CAPITAL MANAGEMENT, L.P.
Increased |
| 1.6M |
+6.5% |
| $4M |
| 0.0% |
| $2.44 |
28 |
| 2025-Q3 | Decreased | 1.5M | -18.7% | $2.8M | 0.0% | $1.82 | 0 |
| 2025-Q2 | Unchanged | 1.9M | 0.0% | $2.3M | 0.0% | $1.20 | 0 |
| 2025-Q1 | Decreased | 1.9M | -10.6% | $3.8M | 0.0% | $2.24 | 0 |
| 2024-Q4 | Decreased | 2.1M | -1.0% | $12.8M | 0.0% | $5.41 | 0 |
| 2024-Q3 | Increased | 2.1M | +1.0% | $15M | 0.0% | $7.16 | 28 |
| 2024-Q2 | Increased | 2.1M | +26.2% | $12.3M | 0.0% | $5.80 | 34 |